Vimarsana
Biggest News Aggregation in the World

Robert Casson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Casson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Casson Today - Breaking & Trending Today

King Charles honours courageous soldiers who took on tyranny with their 'resounding message of courage in pursuit of freedom', writes ROBERT HARDMAN - as world leaders, including Joe Biden, gather on Normandy coast to mark D-Day's 80th anniversary - Vimarsana News

King Charles honours courageous soldiers who took on tyranny with their 'resounding message of courage in pursuit of freedom', writes ROBERT HARDMAN - as world leaders, including Joe Biden, gather on Normandy coast to mark D-Day's 80th anniversary

It was King Charles' first overseas engagement since February's cancer diagnosis, but nothing was going to keep him from this event.

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study - Vimarsana News

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study

Kiora Pharmaceuticals, Inc. has received grant funding from the Choroideremia Research Foundation in support of validating functional vision assessments for patients with profound blindness....

Kiora Pharmaceuticals, Inc.: Kiora's Investigational Treatment for Retinitis Pigmentosa, KIO-301, Demonstrates Visual Function Restoration in Patients Who Are Blind - Vimarsana News

Kiora Pharmaceuticals, Inc.: Kiora's Investigational Treatment for Retinitis Pigmentosa, KIO-301, Demonstrates Visual Function Restoration in Patients Who Are Blind

Encinitas, California--(Newsfile Corp. - April 27, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301,

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP) - Vimarsana News

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is proud to announce that dosing has commenced in the Phase 1 first-in-human trial for KIO-301. This trial represents a remarkable development in the treatment of people with the rare inherited condition, Retinitis Pigmentosa (RP), which currently has no approved cure or standar...

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP) - Vimarsana News

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)

/PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen,...